StockData
BioMarin Pharmaceutical Inc logo

BioMarin Pharmaceutical Inc (BMRN) bonds

BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/3093% above fair value
$58.51+0.52 (+0.90%)

Close on Nov 17, 2026Market cap $11.33BP/E 154.0Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$4.19B
$658.20M due within a year
Net debt
$3.31B
After $874.01M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
37.6×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

Notes and loans outstanding

As tagged in BioMarin Pharmaceutical's 10-Q for the period ended Jun 30, 2026

IssueCouponMaturesAmount issuedCarrying value
1.25% senior subordinated convertible notes due in May 2027 (the 2027 Notes)
Convertible at $137 a share
1.25%2027$600.00M$600.00M
5.5% senior unsecured notes due in February 2034 (the 2034 Notes)5.50%–$850.00M$850.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeAvailableDrawn
Revolving Credit Facility$600.00M––
Senior Secured Revolving Credit Facility$600.00M$600.00M–
Senior Secured Term Loan A Facility$800.00M–$800.00M
Senior Secured Term Loan B Facility$2.00B–$2.00B

See a number that looks wrong?